1. Home
  2. Azioni
  3. Australia
  4. Australian Stock Exchange
  5. Radiopharm Theranostics Limited
  6. Notizie
  7. Altre lingue
    RAD   AU0000181851

RADIOPHARM THERANOSTICS LIMITED

(RAD)
  Rapporto
Tempo differito Australian Stock Exchange  -  03:39 30/06/2022
0.1400 AUD    0.00%
21/06Radiopharm Theranostics Limited nomina Susann Brady-Kalnay nel Consiglio di consulenza scientifica
CI
14/06Le azioni australiane crollano in mezzo al crollo delle azioni globali
MT
14/06Radiopharm Theranostics, Isotopia stipulano un accordo di fornitura per l'isotopo medico; le azioni scendono del 15%
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietÓFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su RADIOPHARM THERANOSTICS LIMITED
21/06Radiopharm Theranostics Limited Appoints Susann Brady-Kalnay to Scientific Advisory Boa..
14/06Australian Shares Plummet Amid Global Equities Selloff
14/06Radiopharm Theranostics, Isotopia Enter Supply Deal for Medical Isotope; Shares Slide 1..
14/06Radiopharm Theranostics Limited and Isotopia Molecular Imaging Ltd Announce Supply Agre..
09/06Radiopharm Theranostics Adds Tumor Destroying, Imaging Agent to Clinical Portfolio; Sha..
09/06Radiopharm Theranostics Limited Signs an Exclusive Sublicensing Agreement with NeoIndic..
06/06Radiopharm Theranostics Limited Appoints Leila Alland as Director
01/06Radiopharm Theranostics Appoints New COO; Shares Decline 3%
01/06Radiopharm Theranostics Appoints Vittorio Puppo as Chief Operating Officer
04/04Radiopharm Theranostics, UCLA-TDG Enter Deal to License Cancer-Cell Targeting Antibody
04/04RADIOPHARM THERANOSTICS: RAD Dual Action Antibody Investor Deck
04/04Radiopharm Theranostics Limited Licenses UCLA Dual Action Antibody
23/03Radiopharm Theranostics Signs Letter of Intent with GenesisCare
28/02AUSTRALIAN IPO REVIEW 2021: Pre–IPO Capital Raises
28/02Radiopharm Theranostics Limited Reports Earnings Results for the Half Year Ended Decemb..
01/02Radiopharm Theranostics Limited Appoints Hester Larkin as Non-Executive Director, Effec..
01/02Radiopharm Theranostics Inks Supply Deal for Cancer Treatment; Shares Rise 5%
31/01Radiopharm and TerraPower Sign Sign Supply Agreement for Actinium-225
24/01Radiopharm Theranostics Acquiring Three Patents for Solid Tumor Diagnostics
24/01Radiopharm Theranostics Limited Acquires Ip Ownership of Radiopharmaceutical Nanobodies
2021Radiopharm Theranostics Announces Management Appointments
2021Radiopharm Theranostics Ends Phase 1 Breast Cancer Imaging Study; Shares Rise 3%
2021Radiopharm Theranostics Announces Completion of Phase 1 Imaging Study in Breast Cancer
2021Radiopharm Theranostics Limited Integrins Technology Featured in Cancers Journal
2021Radiopharm Theranostics Plunges 30% in ASX Debut
2021Radiopharm Theranostics Limited has completed an IPO in the amount of AUD 50 million.
2021Radiopharm Theranostics Limited has filed an IPO in the amount of AUD 50 million.